Potentiation of diethylstilbestrol-induced alterations in the female mouse reproductive tract by transforming growth factor-α transgene expression

Molecular Carcinogenesis

Volumn 17, Issue 3, 1996, Pages 163-173

  Gray, Karen ^a,f   Bullock, Bill ^b   Dickson, Robert ^c   Raszmann, Kimberly ^a   Walmer, David ^a,d   McLachlan, John ^a,g   Merlino, Glenn ^e  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d DUKE UNIVERSITY   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^g TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DES; Reproductive tract carcinogenesis; TGF

Indexed keywords

DIETHYLSTILBESTROL; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; CARCINOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GYNECOLOGIC CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; CARCINOGENS; COCARCINOGENESIS; DIETHYLSTILBESTROL; FALLOPIAN TUBES; FEMALE; GENE EXPRESSION; GENITAL NEOPLASMS, FEMALE; GENITALIA, FEMALE; HUMANS; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; OVARY; TRANSFORMING GROWTH FACTOR ALPHA; TRANSGENES; UTERUS; VAGINA;

ANIMALIA; MUS MUSCULUS;

EID: 0029856078     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199611)17:3<163::AID-MC9>3.3.CO;2-3     Document Type: Conference Paper

References (33)

1. Noller KL, O'Brien PC, Colton T, Kaufman R, Melton LJ. Medical and surgical diseases associated with in utero exposure to diethylstilbestrol. In: Noller LL (ed), Clinical Practice of Gynecology, Elsevier Science Publishing Co., Inc., New York, 1990, pp. 1-7.
2. Iguchi T. Cellular effects of early exposure to sex hormones and antihormones. Int Rev Cytol 139:1-57, 1992.
3. Gray Nelson K, Sakai Y, Eitzman B, Steed T, McLachlan J. Exposure to diethylstilbestrol during a critical developmental period of the mouse reproductive tract leads to persistent induction of two estrogen-regulated genes. Cell Growth Differ 5:595-606, 1994.
4. Metzler M, McLachlan JA. Oxidative metabolites of diethylstilbestrol in the fetal, neonatal, and adult mouse. Biochem Pharmacol 27:1087-1094, 1977.
5. McLachlan JA, Wong A, Degen GH, Barrett JC. Morphological and neoplastic transformation of Syrian hamster embryo fibroblasts by diethylstilbestrol and its analogs. Cancer Res 42:3040-3045, 1982.
6. O'Malley BW, Tsai M-J. Molecular pathways of steroid receptor action. Biol Reprod 46:163-167, 1992.
7. Pollard JW. Regulation of polypeptide growth factor synthesis and growth factor-related gene expression in the rat and mouse uterus before and after implantation. J Reprod Fertil 88:721-731, 1990.
8. Gardner RM, Verner G, Kirkland JL, Stancel GM. Regulation of uterine epidermal growth factor (EGF) receptors by estrogen in the mature rat during the estrous cycle. J Steroid Biochem Mol Biol 32:339-343, 1989.
9. Nelson Gray K, Takahashi T, Lee DC, et al. Transforming growth factor-α is a potential mediator of estrogen action in the mouse uterus. Endocrinology 131:1657-1664, 1992.
10. Bossert NL, Nelson Gray K, Ross KA, Takahashi T, McLachlan JA. Epidermal growth factor binding and receptor distribution in the mouse reproductive tract during development. Dev Biol 142:75-85, 1990.
11. Nelson Gray K, Takahashi T, Bossert NL, Walmer DK, McLachlan JA. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. Proc Natl Acad Sci USA 88:21-25, 1991.
12. Halling A, Forsberg J-G. Acute and permanent growth effects in the mouse uterus after neonatal treatment with estrogens. Reprod Toxicol 7:137-153, 1993.
13. Ignar-Trowbridge DM, Hughes AR, Putney JW Jr, McLachlan JA, Korach KS. Diethylstilbestrol stimulates persistent phosphatidyl-inositol lipid turnover by an estrogen receptor-mediated mechanism in immature mouse uterus. Endocrinology 129:2433-2440, 1991.
14. Takahashi T, Eitzman B, Bossert NL, et al. Transforming growth factors β1, β2, and β3 messenger RNA and protein expression in mouse uterus and vagina during estrogen-induced growth: A comparison to other estrogen-regulated genes. Cell Growth Differ 5:919-935, 1994.
15. Jhappan C, Takayama H, Dickson RB, Merlino G. Transgenic mice provide genetic evidence that TGFα promotes skin tumorigenesis via H-Ras-dependent and H-Ras independent pathways. Cell Growth Differ 5:385-394, 1994.
16. Matsui Y, Halter SA, Holt JT, Hogan BLM, Coffey RJ. Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice. Cell 61:1147-1155, 1990.
17. Sharp R, Babyatsky MW, Takagi H, et al. Transforming growth factor 9α disrupts the normal program of cellular differentiation in the gastric mucosa of transgenic mice. Development 121:149- 161, 1995.
18. Bockman DE, Sharp R, Merlino G. Regulation of terminal differentiation of zymogenic cells by transforming growth factor α in transgenic mice. Gastroenterology 108:447-454, 1995.
19. Takagi H, Sharp R, Takayama H, Anver MR, Ward JM, Merlino G. Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor α transgenic mice. Cancer Res 53:4329-4336, 1993.
20. Vassar R, Hutton ME, Fuchs E. Transgenic overexpression of transforming growth factor α bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis. Mol Cell Biol 12:4643-4653, 1992.
21. Jhappan C, Stable C, Harkins RN, Fausto N, Smith GH, Merlino GT. TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61:1137-1146, 1990.
22. Sandgren EP, Schroeder JA, Qui TH, Palmiter RD, Brinster RL, Lee DC. Inhibition of mammary gland involution is associated with transforming growth factor α but not c-myc-induced tumorigenesis in transgenic mice. Cancer Res 55:3915-3927, 1995.
23. Smith GH, Sharp R, Kordon EC, Jhappan C, Merlino G. Transforming growth factor-α promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. Am J Pathol 147:1081-1096, 1995.
24. Dickson RB, Lippman ME Growth factors in breast cancer. Endocr Rev 16:1-31, 1995.
25. Kenny NJ, Dickson RB. Sex steroid-growth factor interaction in breast cancer. Journal of Mammary Gland Biology and Neoplasia, in press.
26. Ma YJ, Dissen GA, Merlino G, Coquelin A, Ojeda SR. Overexpression of a human transforming growth factor-α (TGFα) transgene reveals a dual antagonistic role of TGFα in female sexual development. Endocrinology 135:1392-1400, 1994.
27. Gray K, Eitzman B, Raszmann K, et al. Coordinate regulation by diethylstilbestrol of the platelet-derived growth factor-A (PDGF- A) and -B chains and the PDGF receptor α- and β-subunits in the mouse uterus and vagina: Potential mediators of estrogen action. Endocrinology 136:2325-2340, 1995.
28. Nagaoka T, Onodera H, Matsushima Y, et al. Spontaneous uterine adenocarcinomas in aged rats and their relation to endocrine imbalance. J Cancer Res Clin Oncol 116:623-628, 1990.
29. Reinartz JJ, George E, Lindgren BR, Niehans GA. Expression of transforming growth factor alpha, epidermal growth factor receptor, and erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival. Hum Pathol 25:1075-1083, 1994.
30. Cohen I. Endometrial changes with tamoxifen: Comparison between tamoxifen-treated and non-treated asymptomatic, postmenopausal breast cancer patients. Gynecol Oncol 52:185-195, 1994.
31. Kudlow JE, Leung AWC, Kobrin MS, Paterson AJ, Asa SL. Transforming growth factor-α in the mammalian brain. J Biol Chem 264:3880-3883, 1989.
32. Futterweit W. In: Futterweit W (ed), Polycystic Ovarian Disease, Springer, New York, 1984, pp. 91-92.
33. Gray K, Bullock B, Dickson R, et al. In: Aldaz CM (ed), Proceedings of the Conference on Etiology of Breast and Gynecological Cancer, John Wiley and Sons, Inc., New York, in press.